BusinessInnovate Biopharmaceuticals’ Dose Response Data for Larazotide Acetate Demonstrating Its Unique Mechanism of Action and Applications in Diseases Caused by Increased Intestinal PermeabilityBy Nasdaq OMXDec 28, 2017, 2:00 PM UTC
BusinessRedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.By Nasdaq OMXSep 13, 2017, 11:00 AM UTC
BusinessInnovate Biopharma’s Pediatric Ulcerative Colitis Drug Granted FDA Orphan DesignationBy Nasdaq OMXSep 6, 2017, 9:06 PM UTC
BusinessInnovate Biopharmaceuticals Submits Orphan Drug Application to FDA for Pediatric Ulcerative Colitis IndicationBy Nasdaq OMXJul 12, 2017, 11:07 AM UTC
